Literature DB >> 2743610

The management of pseudohypacusis in school-age children.

D A Bowdler1, J Rogers.   

Abstract

Pseudohypacusis is a condition in which there is an apparent hearing loss in the absence of clinical or audiological evidence; indeed, audiological assessment for inconsistencies is the mainstay of diagnosis. It is easier to diagnose in children than in adults, due to a child's inability to produce consistently similar results on repeat tests. We have reviewed 15 children with pseudohypacusis, who had an average loss in the right ear of 57 dB, and of 59 dB in the left ear when tested by pure tone audiometry. Eight children were diagnosed by clinical impression and inconsistent pure tone audiograms but in order to confirm the diagnosis in the other seven children further testing with a speech audiogram was necessary and proved sufficient to establish the diagnosis in all cases. The hearing of all 15 children resolved spontaneously at between 2 and 70 months, when treated by careful monitoring and supportive therapy, and none of the children needed psychiatric referral.

Entities:  

Mesh:

Year:  1989        PMID: 2743610     DOI: 10.1111/j.1365-2273.1989.tb00363.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  3 in total

Review 1.  [Nonorganic (functional) hearing loss in children].

Authors:  C-M Schmidt; A Am Zehnhoff-Dinnesen; D Deuster
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

2.  Unilateral pseudohypacusis in children.

Authors:  Jatinder Mohan Chawla; K K Handa; B M Tripathi
Journal:  Indian J Pediatr       Date:  2007-03       Impact factor: 1.967

3.  Pseudohypacusis: the most frequent etiology of sudden hearing loss in children.

Authors:  Ioannis Psarommatis; Psarommatis Ioannis; Georgios Kontorinis; Kontorinis Georgios; Alexandra Kontrogiannis; Kontrogiannis Alexandra; Dimitrios Douniadakis; Douniadakis Dimitrios; Michael Tsakanikos; Tsakanikos Michael
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-23       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.